USX:FOLD - Amicus Therapeutics Inc Amicus Therapeutics Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 3 Nov 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 11.08    -0.060 (-0.54%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

16 Sep 2021


Loading...
Loading...
Loading...

General

CEO: Mr. John F. Crowley

IPO: 2007-05-31

Headquarters: US

Employees: 483

Homepage

Description

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.